Bessemer Group
AZN icon

Bessemer Group’s AstraZeneca AZN Stock Holding History

Bessemer Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.23M Sell
38,133
-4,646
-11% -$874K 0.01% 472
2026
Q1 		$8.44M Sell
42,779
-8,569
-17% -$1.65M 0.01% 357
2025
Q4 		$9.44M Sell
51,348
-1,700
-3% -$298K 0.01% 336
2025
Q3 		$8.14M Buy
53,048
+2,425
+5% +$367K 0.01% 321
2025
Q2 		$7.07M Sell
50,623
-10,303
-17% -$1.44M 0.01% 327
2025
Q1 		$8.96M Buy
60,926
+3,332
+6% +$482K 0.02% 308
2024
Q4 		$7.55M Sell
57,594
-2,057
-3% -$288K 0.01% 342
2024
Q3 		$9.29M Buy
59,651
+898
+2% +$145K 0.02% 322
2024
Q2 		$9.16M Buy
58,753
+11,122
+23% +$1.67M 0.02% 318
2024
Q1 		$6.45M Sell
47,631
-6,486
-12% -$859K 0.01% 356
2023
Q4 		$7.29M Buy
54,117
+410
+0.8% +$53.3K 0.01% 333
2023
Q3 		$7.28M Sell
53,707
-5,533
-9% -$756K 0.02% 308
2023
Q2 		$8.48M Buy
59,240
+20,335
+52% +$2.99M 0.02% 282
2023
Q1 		$5.4M Buy
38,905
+3,775
+11% +$508K 0.01% 327
2022
Q4 		$4.76M Sell
35,130
-1,776
-5% -$223K 0.01% 337
2022
Q3 		$4.05M Buy
36,906
+7,566
+26% +$960K 0.01% 346
2022
Q2 		$3.88M Buy
29,340
+19,062
+185% +$2.5M 0.01% 336
2022
Q1 		$1.36M Sell
10,278
-188
-2% -$22.5K ﹤0.01% 432
2021
Q4 		$1.22M Buy
10,466
+2,296
+28% +$270K ﹤0.01% 425
2021
Q3 		$982K Buy
8,170
+2,963
+57% +$345K ﹤0.01% 415
2021
Q2 		$623K Buy
5,207
+1,432
+38% +$157K ﹤0.01% 518
2021
Q1 		$376K Buy
3,775
+1,445
+62% +$145K ﹤0.01% 611
2020
Q4 		$233K Buy
2,330
+670
+40% +$71K ﹤0.01% 713
2020
Q3 		$181K Hold
1,660
– – ﹤0.01% 749
2020
Q2 		$176K Sell
1,660
-1,863
-53% -$192K ﹤0.01% 1161
2020
Q1 		$315K Buy
3,523
+248
+8% +$23.3K ﹤0.01% 892
2019
Q4 		$326K Buy
3,275
+433
+15% +$40.8K ﹤0.01% 991
2019
Q3 		$253K Buy
2,842
+449
+19% +$38.9K ﹤0.01% 1030
2019
Q2 		$198K Buy
2,393
+772
+48% +$60.5K ﹤0.01% 1080
2019
Q1 		$131K Sell
1,621
-2,439
-60% -$192K ﹤0.01% 1082
2018
Q4 		$308K Buy
4,060
+96
+2% +$7.5K ﹤0.01% 867
2018
Q3 		$313K Buy
3,964
+1,638
+70% +$124K ﹤0.01% 897
2018
Q2 		$163K Buy
2,326
+910
+64% +$65.5K ﹤0.01% 1022
2018
Q1 		$99K Sell
1,416
-711
-33% -$49.2K ﹤0.01% 1128
2017
Q4 		$148K Sell
2,127
-1,415
-40% -$95.4K ﹤0.01% 1069
2017
Q3 		$240K Buy
3,542
+2,344
+196% +$148K ﹤0.01% 1025
2017
Q2 		$82K Sell
1,198
-13,999
-92% -$914K ﹤0.01% 1217
2017
Q1 		$946K Buy
15,197
+417
+3% +$24.3K ﹤0.01% 724
2016
Q4 		$807K Sell
14,780
-200
-1% -$11.4K ﹤0.01% 778
2016
Q3 		$985K Sell
14,980
-10,305
-41% -$674K 0.01% 615
2016
Q2 		$1.53M Buy
25,285
+3,905
+18% +$227K 0.01% 418
2016
Q1 		$1.2M Buy
21,380
+5,209
+32% +$313K 0.01% 441
2015
Q4 		$1.1M Sell
16,171
-10,237
-39% -$671K 0.01% 531
2015
Q3 		$1.68M Buy
26,408
+447
+2% +$29.4K 0.01% 456
2015
Q2 		$1.65M Buy
25,961
+220
+0.9% +$15.1K 0.01% 463
2015
Q1 		$1.76M Buy
25,741
+8,850
+52% +$615K 0.01% 430
2014
Q4 		$1.19M Buy
16,891
+16,105
+2,049% +$1.15M 0.01% 454
2014
Q3 		$56K Hold
786
– – ﹤0.01% 861
2014
Q2 		$58K Sell
786
-305
-28% -$22K ﹤0.01% 858
2014
Q1 		$71K Buy
1,091
+227
+26% +$14.7K ﹤0.01% 792
2013
Q4 		$51K Buy
864
+120
+16% +$6.52K ﹤0.01% 857
2013
Q3 		$38K Sell
744
-1,030
-58% -$51.7K ﹤0.01% 868
2013
Q2 		$84K Buy
+1,774
New +$90.3K ﹤0.01% 679

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bessemer Group's AZN Position: Q2 2026 in Review

Bessemer Group reduced its AstraZeneca (AZN) stake by 11% in Q2 2026, selling an estimated $874K and leaving 38,133 shares worth $7.23M. The position accounts for 0.01% of the portfolio, ranked #472.

Bessemer Group first reported a position in AZN in Q2 2013 and has held it in 53 quarters since. The position peaked at $9.44M in Q4 2025. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Bessemer Group held 38,133 shares of AstraZeneca worth $7.23M as of Q2 2026.
  • Bessemer Group sold 4,646 AstraZeneca shares in Q2 2026, an estimated $874K.
  • AstraZeneca made up 0.01% of Bessemer Group's portfolio in Q2 2026, its #472 holding.
  • Bessemer Group first reported a position in AstraZeneca in Q2 2013 and has held it in 53 quarters since.
  • Bessemer Group's AstraZeneca position peaked at $9.44M in Q4 2025.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.